Back

State of the Art: HFmrEF - The new middle child

27 August 2017 (14:00 - 14:18)
Organised by:
Congress Presentation Part of: Heart failure with mid-range and preserved ejection fraction Miscellaneous ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Rudolf De Boer

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Patterns and prognostic role of N-terminal pro-B-type Natriuretic Peptide in heart failure with mid-range vs. preserved vs. reduced ejection fraction
Doctor G. Savarese (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Prognostic relevance of the 40% left ventricular ejection fraction cut-off in chronic systolic heart failure
Doctor A. Aimo (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Prognostic relevance of preclinical diastolic dysfunction across left ventricular ejection fraction categories. The DAVID-Berg study
Doctor M. Gori (Bergamo, IT)
Abstract Slides Video
Presentation thumbnail
Should we abandon EF to stratify heart failure treatment?
Professor S. Solomon (Boston, US)
Slides Video

Access the full session

Session thumbnail
Heart failure with mid-range and preserved ejection fraction

The Event

Event poster

ESC Congress 2017

27 August 2017 14:00 CET
You may be interested in
thumbnail
Webinar
Unmet needs in HF: patients with LVEF equal or above 40%
12 December 2024
thumbnail
Congress Presentation
Getting to know the middle child
29 June 2021
thumbnail
Congress Session
Heart failure and reduced ejection fraction: the bread and butter of cardiovascular imaging
13 December 2025
thumbnail
Congress Session
Latest registries and observational studies
20 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources